ERGAMISOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ergamisol, and when can generic versions of Ergamisol launch?
Ergamisol is a drug marketed by Janssen Pharma and is included in one NDA.
The generic ingredient in ERGAMISOL is levamisole hydrochloride. There are three drug master file entries for this compound. Additional details are available on the levamisole hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ERGAMISOL?
- What are the global sales for ERGAMISOL?
- What is Average Wholesale Price for ERGAMISOL?
Summary for ERGAMISOL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 106 |
Patent Applications: | 5,709 |
DailyMed Link: | ERGAMISOL at DailyMed |
US Patents and Regulatory Information for ERGAMISOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Janssen Pharma | ERGAMISOL | levamisole hydrochloride | TABLET;ORAL | 020035-001 | Jun 18, 1990 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ERGAMISOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Janssen Pharma | ERGAMISOL | levamisole hydrochloride | TABLET;ORAL | 020035-001 | Jun 18, 1990 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ERGAMISOL
See the table below for patents covering ERGAMISOL around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Philippines | 9277 | METHOD OF AIDING THE REGRESSION OF NEOPLASTIC DISEASE WITH 2,3,5,6-TETRAHYDRO-6-PHENYLIMIDAZO(2,1-B)THIAZOLE | ⤷ Sign Up |
Australia | 5910573 | ⤷ Sign Up | |
France | 2196172 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |